Cassava Sciences | PTIE - Market Capitalization


Cassava Sciences reported $40.7M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
Amgen USD 209.65B 14.21B Aug/2026
Biogen USD 31.9B 5B Jun/2026
Cara Therapeutics USD 110M 80M Aug/2026
Cassava Sciences USD 82M 14M Mar/2026
Eisai JPY 1.2T 219.32B Jun/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Geron USD 979M 24M Aug/2026
J&J USD 611.36B 32.21B Jun/2026
Merck USD 324.18B 6.81B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 153.17B 14.73B Aug/2026
Roche Holding CHF 270B 3.66B Jun/2026